Breaking the Stereotype: Virulence Factor–Mediated Protection of Host Cells in Bacterial Pathogenesis


article has not abstract


Published in the journal: . PLoS Pathog 6(9): e32767. doi:10.1371/journal.ppat.1001057
Category: Opinion
doi: 10.1371/journal.ppat.1001057

Summary

article has not abstract

Bacterial pathogens have evolved extraordinary mechanisms to efficiently infect host organisms. A majority of these pathogens do so by delivering virulence factors into host cells, which act to dampen host defenses or utilize the host as a niche for replication. Although regulation of virulence factor expression by bacterial pathogens is a well known pathogenic mechanism [1], the concept of host-protective virulence factors is emerging. Recently, several strategies by which pathogens appear to be attenuating their own lethality towards host cells have been documented, suggesting that increased hostility and damage of host cells is not necessarily beneficial to the pathogen. Virulence is often defined as the ability of a pathogen to inflict damage on host cells, and the following discussion addresses the concept that increased virulence is not always beneficial to the pathogen, and moderating it to preserve host cells is a mechanism several pathogens use as part of their overall pathogenic strategy. This strategy is well known for obligate intracellular pathogens, but has become an emerging theme in extracellular and facultative intracellular bacteria.

Yersinia spp., Shigella flexneri, Helicobacter pylori, and diarrheagenic Escherichia coli are well known for their ability to kill host cells. For Yersinia, death of infected macrophages dampens cytokine release and enables the pathogen to propagate with minimal challenges from the immune system [2]. Two recent studies suggest that cytotoxicity caused by Yersinia species is tightly regulated. Yersinia pestis, the etiologic agent of plague, and gastroenteritis-inducing Yersinia pseudotuberculosis and Yersinia enterocolitica all encode a cytotoxic virulence factor called YopJ/P (YopJ in the two former species and YopP in the latter), which are translocated into infected cells via a type III secretion system (T3SS) [2], [3]. Altering the cytotoxicity of Y. pseudotuberculosis affects its virulence. Decreased secretion of YopJ was shown to enhance Y. pseudotuberculosis pathogenesis in vivo [4]. Similarly for Y. pestis, enhanced cytotoxicity results in decreased incidence of pneumonic plague in vivo [5]. Tight regulation of cytotoxicity by pathogenic Yersinia is an efficient virulence strategy. Increased apoptosis of infected immune cells decreases production of proinflammatory cytokines; however, some inflammation at the early stages of infection is thought to facilitate tissue damage necessary for movement of bacteria and infected cells to other sites of replication within the host [4].

Enteropathogenic Escherichia coli, enterohaemorrhagic E. coli (EPEC and EHEC, respectively), and Citrobacter rodentium are attaching and effacing (A/E) pathogens that cause severe diarrheagenic disease [6]. The ability of A/E pathogens to kill intestinal epithelial cells has been well documented [7][14]. The type III secreted (T3S) effector EspF has a role in host cell death by causing mitochondrial-dependent apoptosis [11], [15]. We recently found that the T3S effector EspZ modulates cytotoxicity towards host cells. An EPEC espZ mutant (ΔespZ) caused enhanced cytotoxicity in host cells when compared to the wild-type strain [16], which was surprising since the ΔespZ strain is severely attenuated for virulence in vivo [17]. EspZ acts in part through the host transmembrane glycoprotein CD98 to activate focal adhesion kinase (FAK)-based survival pathways (Figure 1) [16]. Others found that the T3S effector NleH also dampens apoptosis of EPEC-infected cells, but via interaction with a Bcl-2-related protein involved in the mitochondrial death pathway (Figure 1) [18]. Unlike EspZ, NleH is not essential for EPEC colonization and only moderately impacts on A/E pathogen disease in vivo [19], [20]; however, there are likely other host-protective virulence factors that act redundantly to NleH during EPEC infection.

Strategies evolved by bacterial pathogens to restrain virulence.
Fig. 1. Strategies evolved by bacterial pathogens to restrain virulence.
(A) EPEC injects effector proteins into intestinal epithelial cells (IECs) via a T3SS. EspF localizes to mitochondria and causes release of cytochrome c into the host cell cytosol, which results in apoptotic death of the host cells. NleH interacts with Bax inhibitor-1 (BI-1), which inhibits release of cytochrome c from mitochondria. EspZ interacts with CD98, which then stimulates phosphorylation of focal adhesion kinase (FAK) to promote survival. Localization of NleH and EspZ in host cells during early stages of EPEC infection is unclear and has been portrayed as shown for simplicity. (B) H. pylori injects virulence factors into gastric epithelial cells via a type IV secretion system in addition to secreting soluble toxins. VacA is an H. pylori–secreted toxin that enters cells by pinocytosis and penetrates intracellular endosome trafficking pathways. VacA causes release of cytochrome c from mitochondria of infected cells, thus mediating host cell apoptosis. CagA is a T4S virulence factor, which prevents both pinocytosis/trafficking and cytochrome c release by VacA. Functions of CagA are dependent on its phosphorylation state, not depicted here. (C) S. flexneri enters IECs from their basolateral surface and then resides in the cell cytoplasm. Prosurvival signaling is initiated by Nod1 activation of Rip2 signaling, which terminates in expression of pro-survival genes, including Bcl-2, via NFκB activation and nuclear translocation. Conversely, S. flexneri facilitates a decrease in the Bcl-2/Bnip3 ratio, which leads to CypD-mediated disruption of mitochondria and oxidative stress-induced necrotic cell death.

H. pylori causes apoptosis of infected gastric epithelial cells [21]. Apoptosis induction by H. pylori has been linked to a secreted toxin called VacA, which induces cytochrome c release from mitochondria (Figure 1) [22]. Recently, it was determined that VacA-mediated apoptosis is counteracted by a type IV secreted (T4S) protein called CagA by both blocking pinocytosis of VacA and inhibiting VacA-mediated cytochrome c release from mitochondria [23] (Figure 1). Interestingly, loss of CagA in a VacA+ H. pylori strain decreases bacterial colonization and the incidence of gastric hyperplasia, adenocarcinoma, and inflammation [24]. Similar to the aforementioned pathogens, H. pylori has evolved a delicate interplay between host-protective and -detrimental virulence factors that are able to fine-tune virulence while promoting their propagation.

S. flexneri, the etiologic agent of bacilliary dysentery, causes death of infected macrophages and epithelial cells [25]. Despite this, several host-protective strategies are employed by S. flexneri. The T3S effector OspE was recently found to enhance adhesion of infected host cells to the underlying extracellular matrix [26]. Whether OspE activates host cell survival pathways directly is unknown; however, its interaction with integrin-linked kinase inhibits sloughing of infected cells into the intestinal lumen [26], consequently preventing anoikis of Shigella-infected cells. An ospE mutant does not colonize as efficiently as wild-type S. flexneri in vivo; thus, OspE may enhance colonization by preventing premature release of infected cells [26]. Epithelial cells succumb to S. flexneri infection via necrotic cell death, which functions to release intracellular bacteria and enhance inflammation [25]. Interestingly, survival pathways involving Rip2/IKKβ/NFκB are activated early during infection, followed by mitochondrial dysfunction and necrotic cell death (Figure 1) [25]. The early expression of pro-survival genes may enable S. flexneri to postpone cell death in a similar manner to EPEC, thus ensuring greater bacterial load prior to dissemination. The mechanism(s) by which S. flexneri enhances NFκB-mediated pro-survival signals are unknown.

All of the above pathogens have evolved strategies to attenuate their own host-damaging virulence factors. In many of these scenarios, removal of host-protective mediators actually reduces pathogenicity of the bacteria. The observation that EPEC encodes a host-protective virulence factor that is essential for its pathogenesis suggests that protecting host cells may be a key to the pathogenic strategies of other bacterial pathogens. The concept of host-protective virulence factors is only just emerging, and we believe host-protective virulence factors will become more apparent in other pathogenic strategies and may become interesting targets to combat bacterial disease. Importantly, virulence phenotypes that appear counterintuitive should not be ignored. Future studies into pathogenic mechanisms of virulent bacteria will likely reveal important roles for effectors or regulatory mechanisms that help the host cell and promote bacterial pathogenesis.


Zdroje

1. MekalanosJJ

1992

Environmental signals controlling expression of virulence determinants in bacteria.

J Bacteriol

174

1

7

2. AepfelbacherM

TrasakC

RuckdeschelK

2007

Effector functions of pathogenic Yersinia species.

Thromb Haemost

98

521

529

3. MillsSD

BolandA

SoryMP

van der SmissenP

KerbourchC

1997

Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein.

Proc Natl Acad Sci U S A

94

12638

12643

4. BrodskyIE

MedzhitovR

2008

Reduced secretion of YopJ by Yersinia limits in vivo cell death but enhances bacterial virulence.

PLoS Pathog

4

e1000067

doi:10.1371/journal.ppat.1000067

5. ZaubermanA

TidharA

LevyY

Bar-HaimE

HalperinG

2009

Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.

PLoS ONE

4

e5938

doi:10.1371/journal.pone.0005938

6. CroxenMA

FinlayBB

2010

Molecular mechanisms of Escherichia coli pathogenicity.

Nat Rev Microbiol

8

26

38

7. VallanceBA

DengW

JacobsonK

FinlayBB

2003

Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium.

Infect Immun

71

3443

3453

8. VallanceBA

DengW

KnodlerLA

FinlayBB

2002

Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection.

Infect Immun

70

2070

2081

9. Abul-MilhM

WuY

LauB

LingwoodCA

Barnett FosterD

2001

Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili.

Infect Immun

69

7356

7364

10. CraneJK

VezinaCM

2005

Externalization of host cell protein kinase C during enteropathogenic Escherichia coli infection.

Cell Death Differ

12

115

127

11. CraneJK

McNamaraBP

DonnenbergMS

2001

Role of EspF in host cell death induced by enteropathogenic Escherichia coli.

Cell Microbiol

3

197

211

12. FlynnAN

BuretAG

2008

Caspases-3, -8, and -9 are required for induction of epithelial cell apoptosis by enteropathogenic E. coli but are dispensable for increased paracellular permeability.

Microb Pathog

44

311

319

13. Barnett FosterD

Abul-MilhM

HuescaM

LingwoodCA

2000

Enterohemorrhagic Escherichia coli induces apoptosis which augments bacterial binding and phosphatidylethanolamine exposure on the plasma membrane outer leaflet.

Infect Immun

68

3108

3115

14. CraneJK

MajumdarS

PickhardtDF3rd

1999

Host cell death due to enteropathogenic Escherichia coli has features of apoptosis.

Infect Immun

67

2575

2584

15. NougayredeJP

DonnenbergMS

2004

Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway.

Cell Microbiol

6

1097

1111

16. ShamesSR

DengW

GuttmanJA

de HoogCL

LiY

2010

The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signaling.

Cell Microbiol

12

1322

1339

17. DengW

PuenteJL

GruenheidS

LiY

VallanceBA

2004

Dissecting virulence: systematic and functional analyses of a pathogenicity island.

Proc Natl Acad Sci U S A

101

3597

3602

18. HemrajaniC

BergerCN

RobinsonKS

MarchesO

MousnierA

2010

NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection.

Proc Natl Acad Sci U S A

107

3129

3134

19. Garcia-AnguloVA

DengW

ThomasNA

FinlayBB

PuenteJL

2008

Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium.

J Bacteriol

190

2388

2399

20. HemrajaniC

MarchesO

WilesS

GirardF

DennisA

2008

Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut.

Infect Immun

76

4804

4813

21. MossSF

CalamJ

AgarwalB

WangS

HoltPR

1996

Induction of gastric epithelial apoptosis by Helicobacter pylori.

Gut

38

498

501

22. GalmicheA

RassowJ

DoyeA

CagnolS

ChambardJC

2000

The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release.

EMBO J

19

6361

6370

23. OldaniA

CormontM

HofmanV

ChiozziV

OregioniO

2009

Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells.

PLoS Pathog

5

e1000603

doi:10.1371/journal.ppat.1000603

24. FrancoAT

JohnstonE

KrishnaU

YamaokaY

IsraelDA

2008

Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors.

Cancer Res

68

379

387

25. CarneiroLA

TravassosLH

SoaresF

TattoliI

MagalhaesJG

2009

Shigella induces mitochondrial dysfunction and cell death in nonmyleoid cells.

Cell Host Microbe

5

123

136

26. KimM

OgawaM

FujitaY

YoshikawaY

NagaiT

2009

Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment.

Nature

459

578

582

Štítky
Hygiena a epidemiologie Infekční lékařství Laboratoř

Článek vyšel v časopise

PLOS Pathogens


2010 Číslo 9

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Příběh jedlé sody
nový kurz
Autoři: MUDr. Ladislav Korábek, CSc., MBA

Krvácení v důsledku portální hypertenze při jaterní cirhóze – od pohledu záchranné služby až po závěrečný hepato-gastroenterologický pohled
Autoři: PhDr. Petr Jaššo, MBA, MUDr. Hynek Fiala, Ph.D., prof. MUDr. Radan Brůha, CSc., MUDr. Tomáš Fejfar, Ph.D., MUDr. David Astapenko, Ph.D., prof. MUDr. Vladimír Černý, Ph.D.

Rozšíření možností lokální terapie atopické dermatitidy v ordinaci praktického lékaře či alergologa
Autoři: MUDr. Nina Benáková, Ph.D.

Léčba bolesti v ordinaci praktického lékaře
Autoři: MUDr. PhDr. Zdeňka Nováková, Ph.D.

Revmatoidní artritida: včas a k cíli
Autoři: MUDr. Heřman Mann

Všechny kurzy
Kurzy Soutěž Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se